Literature DB >> 8321841

Influence of poly(DL-lactide) nanocapsules on the biliary clearance and enterohepatic circulation of indomethacin in the rabbit.

F Fawaz1, F Bonini, M Guyot, A M Lagueny, H Fessi, J P Devissaguet.   

Abstract

Following intravenous administration, the uptake of colloidal drug carriers by cells of the mononuclear phagocyte system, mainly the Kuppfer cells, may concentrate an encapsulated drug close to the liver parenchymal cells and facilitate its biliary excretion and enterohepatic circulation. To test this hypothesis indomethacin was administered (10 mg/kg) in four groups of 10 rabbits each by intravenous infusion at a constant rate over 2 hr, either in its free form (aqueous solution) or as nanocapsules prepared from preformed poly(DL-lactide). Unchanged drug was assayed in plasma of the two control (sham-operated) groups and in both plasma and bile of the two bile-cannulated groups. Pharmacokinetic analysis led to the conclusion that the uptake of nanocapsules by liver macrophages reduces the concentration of the drug by enhancing its total clearance. This enhancement was due to an increase in biliary clearance, as a result of parallel increases in bile concentration and biliary excretion of the drug. It was also demonstrated that nanocapsules enhance the enterohepatic circulation of indomethacin.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321841     DOI: 10.1023/a:1018924219540

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

1.  Anti-metastatic activity in vivo of MDP-L-alanyl-cholesterol (MTP-Chol) entrapped in nanocapsules.

Authors:  W P Yu; G M Barratt; J P Devissaguet; F Puisieux
Journal:  Int J Immunopharmacol       Date:  1991

2.  Effect on cerebral blood flow of orally administered indomethacin-loaded poly(isobutylcyanoacrylate) and poly(DL-lactide) nanocapsules.

Authors:  N Ammoury; H Fessi; J P Devissaguet; M Allix; M Plotkine; R G Boulu
Journal:  J Pharm Pharmacol       Date:  1990-08       Impact factor: 3.765

3.  Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man.

Authors:  K C Kwan; G O Breault; E R Umbenhauer; F G McMahon; D E Duggan
Journal:  J Pharmacokinet Biopharm       Date:  1976-06

4.  Enterohepatic circulation of indomethacin and its role in intestinal irritation.

Authors:  D E Duggan; K F Hooke; R M Noll; K C Kwan
Journal:  Biochem Pharmacol       Date:  1975-10-01       Impact factor: 5.858

5.  Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats.

Authors:  N Ammoury; H Fessi; J P Devissaguet; M Dubrasquet; S Benita
Journal:  Pharm Res       Date:  1991-01       Impact factor: 4.200

6.  Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice.

Authors:  N Chiannilkulchai; N Ammoury; B Caillou; J P Devissaguet; P Couvreur
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  Disposition kinetics and oral bioavailability of vincamine-loaded polyalkyl cyanoacrylate nanoparticles.

Authors:  P Maincent; R Le Verge; P Sado; P Couvreur; J P Devissaguet
Journal:  J Pharm Sci       Date:  1986-10       Impact factor: 3.534

8.  The biliary elimination and enterohepatic circulation of ibuprofen in rats.

Authors:  K Dietzel; W S Beck; H T Schneider; G Geisslinger; K Brune
Journal:  Pharm Res       Date:  1990-01       Impact factor: 4.200

9.  Pharmacokinetics of an indomethacin pro-drug: apyramide after intravenous administration in dog.

Authors:  M Cociglio; J Bres; D Sauvaire; R Alric; M Richard
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1991 Oct-Dec       Impact factor: 2.441

10.  Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam.

Authors:  C Benveniste; R Striberni; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

View more
  7 in total

Review 1.  Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.

Authors:  Michael S Roberts; Beatrice M Magnusson; Frank J Burczynski; Michael Weiss
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Optimization of polylactic-co-glycolic acid nanoparticles containing itraconazole using 2(3) factorial design.

Authors:  Mukdavan Prakobvaitayakit; Ubonthip Nimmannit
Journal:  AAPS PharmSciTech       Date:  2003-12-31       Impact factor: 3.246

3.  Pharmacokinetics, Tissue Distribution and Excretion of Ag2S Quantum Dots in Mice and Rats: the Effects of Injection Dose, Particle Size and Surface Charge.

Authors:  Jaber Javidi; Azadeh Haeri; Fatemeh Nowroozi; Simin Dadashzadeh
Journal:  Pharm Res       Date:  2019-02-04       Impact factor: 4.200

Review 4.  Encapsulation of nucleic acids and opportunities for cancer treatment.

Authors:  Lisa Brannon-Peppas; Bilal Ghosn; Krishnendu Roy; Kenneth Cornetta
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

5.  Acute changes in muscle blood flow and concomitant muscle damage after an intramuscular administration.

Authors:  Pierre Jean Ferré; Eckart Thein; Isabelle Raymond-Letron; Pierre-Louis Toutain; Hervé Pierre Lefebvre
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

6.  Rhodamine-loaded poly(lactic-co-glycolic acid) nanoparticles for investigation of in vitro interactions with breast cancer cells.

Authors:  Tania Betancourt; Kunal Shah; Lisa Brannon-Peppas
Journal:  J Mater Sci Mater Med       Date:  2008-09-25       Impact factor: 3.896

Review 7.  Nanotechnology: intelligent design to treat complex disease.

Authors:  Patrick Couvreur; Christine Vauthier
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.